Related Experiment Video
Updated: Jun 9, 2026

RhoC GTPase Activation Assay
Published on: August 22, 2010
RhoC GTPase activation assay
Michelle Lucey1, Heather Unger, Kenneth L van Golen
1Department of Biological Sciences, The Center for Translational Cancer Research, University of Delaware, USA.
Abstract:
RhoC GTPase has 91% homology to RhoA GTPase. Because of its prevalence in cells, many reagents and techniques for RhoA GTPase have been developed. However, RhoC GTPase is expressed in metastatic cancer cells at relatively low levels. Therefore, few RhoC-specific reagents have been developed. We have adapted a Rho activation assay to detect RhoC GTPase. This technique utilizes a GST-Rho binding domain fusion protein to pull out active RhoC GTPase. In addition, we can harvest total protein at the beginning of the assay to determine levels of total (GTP and GDP bound) RhoC GTPase. This allows for the determination of active versus total RhoC GTPase in the cell. Several commercial versions of this procedure have been developed however, the commercial kits are optimized for RhoA GTPase and typically do not work well for RhoC GTPase. Parts of the assay have been modified as well as development of a RhoC-specific antibody.
Insights
Researchers developed a new assay to detect RhoC GTPase activity, crucial for understanding metastatic cancer. This method overcomes limitations of existing RhoA GTPase kits, enabling specific RhoC analysis.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- RhoC GTPase shares high homology with RhoA GTPase, but its low expression in metastatic cancers limits specific study.
- Existing RhoA GTPase assays and reagents are not optimized for RhoC GTPase, hindering research.
- There is a need for specific tools to investigate RhoC GTPase's role in cancer progression.
Purpose of the Study:
- To adapt and validate a Rho activation assay for the specific detection of RhoC GTPase.
- To enable the quantification of active versus total RhoC GTPase in cellular samples.
- To address the lack of RhoC-specific reagents and improve cancer research tools.
Main Methods:
- Adaptation of a Rho activation assay using a GST-Rho binding domain fusion protein for RhoC pull-down.
- Harvesting total protein to determine total RhoC GTPase levels (GTP and GDP bound).
- Development of a RhoC-specific antibody to enhance assay specificity and detection.
Main Results:
- Successfully adapted a Rho activation assay to specifically detect RhoC GTPase.
- Established a method to quantify active RhoC GTPase relative to total RhoC GTPase.
- Demonstrated improved performance compared to commercial kits optimized for RhoA GTPase.
Conclusions:
- The developed assay provides a reliable method for RhoC GTPase activity measurement.
- This technique facilitates the study of RhoC GTPase in metastatic cancers.
- The RhoC-specific antibody and modified assay enhance research capabilities in cancer biology.
More Related Videos
13:51Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
Published on: November 11, 2018
11:28Affinity Precipitation of Active Rho-GEFs Using a GST-tagged Mutant Rho Protein (GST-RhoA(G17A)) from Epithelial Cell Lysates
Published on: March 31, 2012
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Activation and Inactivation of G Proteins
GTPases and their Regulation
Large G-proteins, also known...
GTPases and their Regulation
Large G-proteins, also known...
Cell Polarization by Rho Proteins